Novel Biologic for Sjogren’s Clears Penultimate Hurdle

(MedPage Today) — CHICAGO — An investigational biologic against B-cell activating factor (BAFF) appeared effective in treating Sjögren’s disease in twin phase III trials, a researcher reported here, although salivation wasn’t enhanced…